Private equity firm True North and Niva Bupa Health Insurance chief Krishnan Ramachandran divested a combined 10 per cent stake in the health insurer for Rs 1,507 crore through open market transactions.
Tata Sons boardroom battle intensifies but Tata Group stocks remain unbothered. Should you buy?
Tata Sons has rejected Noel Tata’s objections to N Chandrasekaran’s reappointment, saying the board’s decision was valid and made in accordance with the company’s Articles